Company performance
Add to research
Current Price
as of Apr 21, 2025$3.11
P/E Ratio
N/A
Market Cap
$33.54M
Description
Add to research
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Metrics
Add to research
Overview
- HQDallas, TX
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerLTRN
- Price$3.11-9.06%
Trading Information
- Market cap$33.54M
- Float74.47%
- Average Daily Volume (1m)43,257
- Average Daily Volume (3m)81,519
- EPS-$1.93
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$20.78M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$22.03M
- EV$10.56M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.58
- Debt/Equity1.15
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account